A study has shown no difference in outcome for adding thyroxine to antithyroid medication and continuing thyroxine versus placebo after antithyroid medication withdrawal.
12.
The term Hashimoto's encephalopathy is used to describe an encephalopathy of presumed autoimmune origin characterized by high titres of antithyroid peroxidase antibodies.
13.
The risk of recurrence is approximately 40 50 % and lifelong treatment with antithyroid drugs carries some side effects such as agranulocytosis and liver disease.
14.
?-blockers ( such as propranolol ) may be used to inhibit the sympathetic nervous system symptoms of tachycardia and nausea until such time as antithyroid treatments start to take effect.
15.
These two markers are a positive specificity 98 % ), a negative TSHR-Ab at the end of antithyroid drug treatment is associated with a 78 % chance of remaining in remission.
16.
These two markers are an elevated level of specificity 98 % ), a negative TSHR-Ab at the end of antithyroid drug treatment is associated with a 78 % chance of remaining in remission.
17.
Therapy with radioiodine is the most common treatment in the United States, while antithyroid drugs and / or thyroidectomy are used more often in Europe, Japan, and most of the rest of the world.
18.
The metabolic rate can be affected by some drugs, such as antithyroid agents, drugs used to treat hyperthyroidism, such as propylthiouracil and methimazole, bring the metabolic rate down to normal and restore euthyroidism.
For an overactive thyroid, which produces too much hormone, there are three options : radioactive iodine, a one-time oral treatment that destroys the gland; antithyroid drugs, which have a success rate of 1 out of 3; or surgery to remove the gland.
